Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1023 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To generate a list of potential genetic markers that correlate with an increased risk of life-threatening arrhythmias.

To evaluate ECG-based risk markers such as heart rate variability and T-wave Alternans for their association with arrhythmic events.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Performance of AFGen1

NCT06076798

Atrial Fibrillation Afib ECG

COMPLETED

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

NCT07116525

RECRUITING NA

A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter

NCT05373862

COMPLETED NA

Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection

NCT04076917

Atrial Fibrillation

TERMINATED

Clinical Performance of the AFGen1 Device Over a 7-day Period

NCT05295056

Atrial Fibrillation Afib Irregular Heart Beat +4 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective is to establish the role of genetics in life-threatening arrhythmias leading to sudden cardiac death (SCD) and the potential utility of genetic markers in risk stratification of patients to receive an implantable cardiac defibrillator (ICD). The successful accomplishment of this goal would serve as the basis for future work on a specific diagnostic test that can be used to assess risks of threatening arrhythmias in order to quality patients for implantation of an ICD.

* to identify single nucleotide polymorphisms (SNPs) that can be used to identify individuals in need of an ICD.

The secondary objectives involve more detailed analysis to search for potentially unidentified genetic markers of risk for SCD.

1. to identify genes associated with SCD susceptibility.
2. to identify risk factors associated with SCD as found in the case report form (CRF).
3. to correlate SNPs with co-morbidities in the subjects as found in the CRF information.
4. to study the association between parameters derived from Holter recordings and predictors of life-threatening arrhythmias.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Death, Sudden, Cardiac Ventricular Fibrillation Tachycardia Atrial Fibrillation Sick Sinus Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The following criteria apply to all subjects:

* Subject has an ICD or CRT ICD implanted
* Subject must be on optimal medical therapy
* Subject is a Caucasian with all 4 grandparents believed to be Caucasian
* Subject has had a myocardial infarction (MI) prior to ICD implantation
* Subject is willing and able to comply with the study protocol
* Subject is willing and able to sign and date the study Informed Consent and HIPAA Authorization (US)

The following criteria apply to case subjects only:

* Subject is at least 40 years of age at time of ICD implantation
* Subject has at least one documented life-threatening arrhythmia (LTA) on their ICD that can transferred as a save-to-disk or has had an LTA documented in their medical history. LTA is defined as a true VT/VF episode with cycle length less than or equal to 400ms that was terminated by the device.

The following criteria apply to control subjects only:

* Subject is currently at least 70 years of age
* Subject has haad currently implanted Medronic ICD for a minimum of three years

Exclusion Criteria

The following criteria apply to all subjects:

* Subject has received a bone marrow or heart transplant at any time
* Subject has a previously identified cause for arrhythmias (Brugada, LQT, HCM)

The following criteria apply to control subjects only:

* Subject has had a potentially LTA documented on their ICD
* Subject was previously identified as having a LTD at any time in life
* Subject has had the memory on their ICD cleared at any time in the past three years.

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No